JAK inhibition for treatment of psoriatic arthritis in Down syndrome

por Pham, Andrew T., Rachubinski, Angela L., Enriquez-Estrada, Belinda, Worek, Kayleigh, Griffith, Melissa, Espinosa, Joaquin M.
Publicado 2021

IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome

por Araya, Paula, Kinning, Kohl T., Coughlan, Christina, Smith, Keith P., Granrath, Ross E., Enriquez-Estrada, Belinda A., Worek, Kayleigh, Sullivan, Kelly D., Rachubinski, Angela L., Wolter-Warmerdam, Kristine, Hickey, Francis, Galbraith, Matthew D., Potter, Huntington, Espinosa, Joaquin M.
Publicado 2022

Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition

por Galbraith, Matthew D., Rachubinski, Angela L., Smith, Keith P., Araya, Paula, Waugh, Katherine A., Enriquez-Estrada, Belinda, Worek, Kayleigh, Granrath, Ross E., Kinning, Kohl T., Paul Eduthan, Neetha, Ludwig, Michael P., Hsieh, Elena W. Y., Sullivan, Kelly D., Espinosa, Joaquin M.
Publicado 2023

Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity

por Araya, Paula, Waugh, Katherine A., Sullivan, Kelly D., Núñez, Nicolás G., Roselli, Emiliano, Smith, Keith P., Granrath, Ross E., Rachubinski, Angela L., Enriquez Estrada, Belinda, Butcher, Eric T., Minter, Ross, Tuttle, Kathryn D., Bruno, Tullia C., Maccioni, Mariana, Espinosa, Joaquín M.
Publicado 2019